You are here

Article Text

Article menu
Letters to the editor
Economic disadvantages of palivizumab
  1. R A SMITH, Consultant Paediatrician
  1. Department of Paediatrics, Child Development Unit
  2. Birch Hill Hospital, Rochdale Infirmary
  3. Whitehall Street, Rochdale OL12 0NB, UK
    1. R BOON, Sp Registrar in Paediatrics
    1. Department of Paediatrics, Child Development Unit
    2. Birch Hill Hospital, Rochdale Infirmary
    3. Whitehall Street, Rochdale OL12 0NB, UK

      https://doi.org/10.1136/adc.82.4.336h

      Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Editor,—We would fully agree with Dr Sanjeev Deshpande's appraisal of the economic disadvantages of palivizumab (Arch Dis Child2000;82:88–90) and …

        View Full Text